drugset
Drugs / ATG
last change Sep 2021 re-read 3 minutes ago

ATG

Protein / enzyme biologic

Developed for
chronic graft versus host disease
Investigated by
First Affiliated Hospital, Sun Yat-Sen University · Nanfang Hospital, Southern Medical University · Second Affiliated Hospital, Sun Yat-Sen University · Zhujiang Hospital

Trials 1

today NCT03190733 · Ph 4
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03190733 Aug 2017 → Sep 2020 acute leukemia, chronic graft versus host disease Zhujiang Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ATG ClinicalTrials.gov intervention name — accepted as the source's own label NCT03190733 ↗
Modality Protein / enzyme biologic “antithymocyte globulin (ATG)” NCT03190733 ↗
Route Intravenous “ATG will be intravenously infused via a central venous catheter” NCT03190733 ↗